Diverticulitis is inflammation involving one or more diverticula—pouchlike projections from the wall of the digestive tract—and the surrounding tissues. It most often affects the large intestine, particularly the sigmoid colon in Western populations. It differs from diverticulosis, the presence of diverticula without necessarily having inflammation, and from diverticular bleeding, which usually results from injury to a blood vessel rather than an acute inflammatory episode.
The disease ranges from a localized, self-limited inflammatory process to an abdominal emergency involving an abscess, free perforation, bowel obstruction, or widespread infection. Typical manifestations include lower abdominal pain, tenderness, changes in bowel habits, and sometimes fever. Imaging, especially computed tomography, distinguishes uncomplicated inflammation from conditions requiring drainage or an operation.
Understanding of diverticulitis has changed substantially since the late twentieth century. Diverticulosis is now recognized as much more common than diverticulitis; antibiotics are not necessary for every uncomplicated episode; and elective surgery is no longer determined simply by counting attacks. Modern classification and treatment emphasize anatomical complications, physiological severity, immune status, and the effects of disease on everyday life.
Anatomical basis and related conditions
A diverticulum is an outpouching from a hollow organ. Most acquired colonic diverticula are “false” diverticula: the mucosa and submucosa protrude through the muscular layer rather than containing every layer of the bowel wall. They commonly form where small penetrating arteries, the vasa recta, pass through the muscle. These sites create natural points of relative weakness. The resulting sacs communicate with the intestinal lumen through openings that vary in width and may contain stool or retained material.
The sigmoid colon, between the descending colon and the rectum, is especially susceptible in many European and North American populations. Its relatively narrow lumen, muscular organization, and segmental contractions contribute to the mechanical environment in which diverticula develop. Structural changes include thickening of the muscle layer and alterations in connective tissue. Diverticula may nevertheless occur throughout the colon. Right-sided diverticula are relatively more prominent in several East Asian populations, and inflammation there can closely resemble appendicitis.
Three terms describe different clinical states. Diverticulosis means that diverticula are present. Diverticular disease is a broader clinical expression used for symptoms or complications attributed to diverticula, although its precise scope differs among publications. Diverticulitis specifically denotes inflammation involving a diverticulum and adjacent tissue. Many people with diverticulosis never develop either symptoms or inflammation. Finding diverticula during an unrelated examination therefore does not establish the cause of abdominal symptoms.
Diverticular bleeding is another distinct complication. It generally follows damage to a vessel associated with a diverticulum and often produces painless rectal bleeding. Substantial bleeding is not a defining feature of acute diverticulitis, and the two processes usually occur separately. Another associated condition, segmental colitis associated with diverticulosis, primarily affects the mucosa between diverticula, usually in a segment of left colon. Its endoscopic appearance, distribution, and microscopic features distinguish it from inflammation centered on a diverticulum.
Diverticulitis can also occur outside the colon. Acquired diverticula of the small intestine, especially the jejunum, occasionally become inflamed or perforate. Meckel’s diverticulum, a congenital remnant of the embryonic vitelline duct, is anatomically different: it is a true diverticulum containing all bowel-wall layers and arises from the ileum. Its inflammation may mimic appendicitis. Although these conditions share the descriptive term “diverticulitis,” their causes, anatomical relationships, diagnostic problems, and surgical treatment differ from those of ordinary colonic disease.
Epidemiology and associated risk factors
The frequency of diverticulitis is closely related to, but not identical with, the frequency of diverticulosis. Diverticulosis becomes increasingly common with age, particularly in populations where left-sided disease predominates. Diverticulitis also becomes more frequent in older adults, but it occurs in younger adults and is not exclusively a disease of old age. Studies from several high-income countries have reported increasing diagnoses or hospital admissions among younger age groups. Such trends reflect a combination of disease occurrence, imaging use, admission practices, and changes in population characteristics.
Older accounts often stated that 10–25% of people with diverticulosis would eventually develop diverticulitis. More recent longitudinal studies suggest substantially lower risks. In a 2013 study of people with diverticulosis detected at colonoscopy, approximately 4% developed clinically diagnosed diverticulitis over about 11 years; the proportion was lower when a stricter definition requiring imaging or operative confirmation was used. This does not supply a universal lifetime probability, because study populations, follow-up duration, and diagnostic criteria differ. It does demonstrate why the presence of diverticula should not be equated with inevitable inflammatory disease.
Geographical variation is important. Left-sided disease predominates in many Western populations, whereas right-sided diverticulosis and diverticulitis account for a larger share of cases in several Asian populations. These patterns probably reflect interacting inherited, anatomical, environmental, and behavioral factors. Comparisons of incidence between countries require care: administrative codes may combine different forms of diverticular disease, and hospital-based studies omit many episodes managed outside hospital. Increasing access to cross-sectional imaging can also increase recognition of mild disease and right-sided cases.
Observational research associates diverticulitis with obesity, smoking, physical inactivity, and certain dietary patterns. Higher consumption of red meat, especially unprocessed red meat, has been associated with increased risk in some prospective cohorts. Dietary patterns rich in fruits, vegetables, legumes, and whole grains have generally been associated with lower risk. These associations do not establish that an individual exposure directly causes a particular attack. The relationship between dietary fiber, diverticulum formation, and subsequent inflammation is more complex than the older theory that insufficient fiber alone explains the entire disease.
Medication exposure and inherited susceptibility also influence risk. Regular use of nonsteroidal anti-inflammatory drugs has been associated with diverticulitis and its complications. Corticosteroids and other causes of impaired immune function are associated with more difficult clinical courses. Twin studies and genetic studies support a substantial inherited contribution, with implicated biological pathways involving connective tissue, intestinal movement, and immune regulation. No single genetic variant explains most cases, and routine genetic testing is not part of ordinary diverticulitis assessment.
Mechanisms of inflammation and tissue injury
The classic explanation of diverticulitis proposed that stool or a hardened fecal concretion obstructs the neck of a diverticulum. Retained contents, local pressure, and impaired blood supply would then injure the mucosa, permit bacterial invasion, and cause a small perforation. This remains a plausible sequence in some cases, but obstruction has not been demonstrated as a universal initiating event. Current models treat diverticulitis as the result of interacting mechanical, structural, microbial, and host inflammatory processes rather than a single uniform mechanism.
The wall of an acquired diverticulum lacks the full muscular support of the surrounding colon. Local mechanical stress or mucosal injury can therefore bring intestinal contents into contact with tissues outside the bowel. Small areas of leakage may be contained by nearby fat, mesentery, or adjacent organs. The resulting inflammation produces bowel-wall thickening and inflammatory change in the surrounding fat. These are central findings on computed tomography. Although “microperforation” is often used to describe this process, a perforation is not directly demonstrable in every uncomplicated episode.
The immune system determines how effectively local injury is contained. Recruitment of inflammatory cells, release of signaling molecules, and changes in local blood vessels produce pain, swelling, and sometimes systemic symptoms. A localized collection of pus forms an abscess. Failure of containment can permit intestinal contents to enter the peritoneal cavity, causing peritonitis. Systemic responses to severe infection may progress to sepsis, with organ dysfunction arising from a dysregulated response to infection rather than simply from the presence of bacteria in the bloodstream.
The gut microbiome is a major subject of investigation because colonic organisms participate in established infection and may influence mucosal immune responses before an attack. Studies have reported differences in microbial composition and metabolic activity among people with diverticular disease, but findings are inconsistent. Diet, recent antibiotics, bowel preparation, age, and the effects of inflammation itself complicate interpretation. No specific organism or reproducible microbial signature has been established as the universal cause, and microbiome testing is not a standard diagnostic method for diverticulitis.
Repeated or persistent inflammation can remodel tissues. Fibrosis may narrow the bowel lumen, producing a stricture, while adherence to a nearby organ can precede formation of an abnormal communication, or fistula. The bladder is a frequent destination because of its proximity to the sigmoid colon. Persistent symptoms after an episode, however, do not always indicate continuing tissue inflammation. Altered intestinal movement and increased sensitivity of visceral nerves can produce pain after radiological inflammation has resolved, making structural disease and post-inflammatory sensory dysfunction important distinctions.
Clinical manifestations and severity classification
The typical presentation of sigmoid diverticulitis is relatively constant pain in the left lower abdomen, often accompanied by localized tenderness and a change in bowel habits. Constipation and diarrhea can both occur. Fever, reduced appetite, and nausea are common but not universal. Symptoms often develop over hours to several days. Right-sided inflammation produces right-sided pain and may be difficult to distinguish clinically from appendicitis. A pelvic sigmoid segment can cause suprapubic discomfort, urinary irritation, or symptoms that seem disproportionate to findings in the left lower abdomen.
Clinical expression varies with age, immune status, and the extent of inflammation. Older adults may have less prominent fever or tenderness despite significant disease. People receiving immunosuppressive treatment may also have muted inflammatory signs. A localized inflammatory mass can occasionally be palpable. In contrast, generalized tenderness, guarding, abdominal rigidity, circulatory instability, or altered mental status may accompany widespread peritoneal inflammation or severe systemic illness. Symptoms and examination alone cannot reliably establish the anatomical extent of disease.
The most widely used practical distinction is between uncomplicated and complicated diverticulitis. Uncomplicated disease consists of localized inflammation without a major abscess, fistula, obstruction, or uncontained perforation. Complicated disease includes one or more of these structural problems. Definitions are not completely uniform: a small amount of gas immediately outside the bowel, without systemic illness or a collection, is not classified as complicated disease by every guideline. Consequently, an imaging description is often more informative than a severity label alone.
The Hinchey classification, published by E. John Hinchey and colleagues in 1978, originally described operative findings in perforated diverticular disease. Stage I represented a pericolic abscess, stage II a pelvic, intra-abdominal, or retroperitoneal abscess, stage III generalized purulent peritonitis, and stage IV generalized fecal peritonitis. Modified versions incorporate computed tomography and distinguish localized inflammation from different abscess patterns. Because several modifications exist, a stage number without identification of the classification system can be ambiguous. The original system also does not describe the full spectrum of uncomplicated outpatient disease.
Some presentations are dominated by a complication rather than a typical painful attack. A colovesical fistula can cause recurrent urinary tract infections, air passed during urination, or fecal material in urine. A colovaginal fistula may cause passage of gas or stool through the vagina. A stricture can produce progressive distension, constipation, or bowel obstruction. These findings require distinction from malignancy and other intestinal disorders. Neither the intensity of pain nor the number of previous attacks, by itself, reliably predicts which structural complication is present.
Diagnostic assessment and competing diagnoses
Assessment combines the medical history, physical examination, laboratory tests, and, when needed, imaging. Relevant information includes the location and duration of pain, previous imaging-confirmed episodes, bowel and urinary symptoms, medication exposure, immune status, and previous abdominal operations. Examination establishes whether tenderness is localized or generalized and whether there are signs of dehydration, obstruction, or systemic illness. Clinical suspicion alone is insufficiently specific: several intestinal, urinary, gynecological, and vascular conditions can produce similar symptoms.
A complete blood count may show an increased white-cell count, while C-reactive protein provides a measure of systemic inflammation. Neither finding is specific for diverticulitis, and normal results do not invariably exclude it. Higher inflammatory-marker concentrations tend to accompany more extensive disease, but no laboratory threshold replaces imaging or clinical assessment. Kidney function testing is relevant to physiological assessment and decisions involving intravenous contrast. Urinalysis may help identify urinary disease, although inflammation near the bladder can itself cause urinary abnormalities.
Computed tomography of the abdomen and pelvis is the principal cross-sectional imaging method in many health systems. Typical findings include diverticula, segmental colonic wall thickening, and inflammatory stranding in the surrounding fat. Imaging can also demonstrate an abscess, extraluminal gas, obstruction, or a suspected fistula. Intravenous contrast material often improves assessment of complications and alternative diagnoses. In appropriate settings, CT has diagnostic sensitivity and specificity around 95%, although performance depends on technique, reader experience, and the population being examined. Repeat imaging is not necessary merely to document resolution in every uncomplicated case.
Ultrasonography avoids ionizing radiation and can identify an inflamed diverticulum, thickened bowel, and adjacent inflammatory change. Its usefulness depends strongly on operator expertise, body habitus, bowel gas, and the depth of the affected segment. Some systems use ultrasound first and CT when findings are uncertain or complications are suspected. Magnetic resonance imaging is another radiation-free option, although availability, examination time, and emergency workflows limit its routine use. Imaging choices during pregnancy take account of both diagnostic needs and fetal exposure.
The differential diagnosis includes colorectal cancer, appendicitis, infectious or ischemic colitis, inflammatory bowel disease, kidney stones, urinary infection, and gynecological conditions. Epiploic appendagitis, inflammation associated with infarction of a small fatty appendage on the colon, is an important imaging mimic. Colonoscopy is generally deferred during active acute inflammation because instrumentation may be difficult and may increase perforation risk. After recovery, it can identify a cancer or another mucosal disorder that resembled diverticulitis, particularly when the original episode was complicated or the imaging appearance was atypical.
Nonoperative treatment of acute disease
Nonoperative care is appropriate for many episodes, but it encompasses different levels of treatment. Selected patients with mild uncomplicated disease receive outpatient care, while others require hospital observation, intravenous fluids, treatment of vomiting, or closer monitoring. Admission decisions take account of physiological stability, the ability to tolerate oral intake, coexisting illness, immune status, pain control, and the feasibility of reassessment. The distinction between outpatient and inpatient care is therefore not determined by the CT label alone.
Supportive treatment addresses fluid balance, symptoms, and temporary difficulty eating. A restricted or clear-liquid diet is sometimes used briefly for comfort during an acute episode, with intake expanded as symptoms improve. Evidence does not establish prolonged bowel rest as necessary for every uncomplicated attack. Intravenous fluids are used when oral intake is inadequate or dehydration is present. Analgesic selection depends on the clinical setting, existing illnesses, and medication risks. Persistent inability to eat or an unexpectedly slow recovery can prompt reassessment for an unrecognized complication or a different diagnosis.
A major change in practice has been selective rather than universal use of antibiotics for uncomplicated disease. The Swedish–Icelandic AVOD trial, published in 2012, and the Dutch DIABOLO trial, published in 2017, compared strategies with and without antibiotics in selected patients with imaging-confirmed uncomplicated diverticulitis. Neither demonstrated a clear routine benefit from antibiotics across the measured clinical outcomes in those populations. Subsequent analyses and professional guidance have supported observation without antibiotics for some immunocompetent patients with mild disease and no systemic illness.
These findings do not mean that antibiotics have no role in diverticulitis. Their use remains established in complicated disease and in patients with systemic infection. Guidelines also favor antibiotics for immunocompromised patients and for selected uncomplicated cases with greater illness severity, substantial comorbidity, prolonged or refractory symptoms, vomiting, or concerning laboratory or imaging features. When prescribed, regimens generally cover enteric gram-negative bacteria and anaerobes. Drug selection and duration vary with disease severity, allergies, organ function, local resistance patterns, and whether an infected collection has been adequately controlled.
Observation is an active clinical strategy rather than a declaration that inflammation is harmless. Clinical progress, oral intake, pain, fever, and signs of complication determine whether treatment remains appropriate. Deterioration or failure to improve may lead to additional imaging, admission, or intervention. Avoiding unnecessary antibiotics reduces exposure to adverse drug effects, Clostridioides difficile infection, and antimicrobial resistance. The evidence supporting selective antibiotic use applies most directly to the carefully defined populations enrolled in randomized controlled trials, not automatically to every patient carrying a diagnosis of diverticulitis.
Abscess drainage and operative treatment
An abscess changes management because antibiotics may penetrate an organized infected collection inadequately and because continuing contamination can sustain infection. Small abscesses are often treated with antibiotics alone, whereas larger, accessible collections may undergo image-guided percutaneous drainage. Drainage places a catheter into the collection through the skin, usually under CT or ultrasound guidance. Published guidelines use different size thresholds, commonly within a range of about 3–5 cm. Size is only one factor: location, safe access, physiological condition, and response to treatment are also important.
Percutaneous drainage is performed within interventional radiology and can control infection without an immediate major operation. It may allow inflamed tissues to settle before any later resection. Not every abscess has a safe drainage route, and some contain multiple compartments that do not drain effectively. Persistent sepsis, enlarging collections, or failure of nonoperative treatment may necessitate surgery. Fluid obtained during drainage can be cultured, allowing antibiotic treatment to be adjusted when clinically relevant organisms or resistance patterns are identified.
Emergency surgery is most clearly indicated when uncontrolled contamination, generalized peritonitis, or physiological deterioration requires definitive source control. The usual operation removes the affected colonic segment. In Hartmann’s procedure, the diseased sigmoid colon is resected, the rectal end is closed, and an end colostomy is formed. This avoids an immediate bowel join but leaves a stoma that may require another substantial operation to reverse. Some patients never undergo reversal because of subsequent illness, operative risk, or personal preference.
An alternative is resection with primary anastomosis, reconnecting the remaining bowel during the initial operation, sometimes with a temporary diverting ileostomy. Randomized studies support this approach in selected, sufficiently stable patients, with a greater likelihood of eventual stoma freedom than after Hartmann’s procedure. Selection depends on circulatory stability, organ dysfunction, contamination, tissue quality, comorbidities, and surgical expertise. Laparoscopic lavage, which washes out infected fluid without removing the sigmoid colon, has also been studied in selected purulent peritonitis. Concerns about unresolved disease, abscesses, and reintervention have prevented it from becoming a routine substitute for resection.
Elective surgery after recovery has different objectives: treatment of a fistula or symptomatic stricture, prevention of selected recurrent complications, or relief of substantial ongoing disease burden. The historical practice of recommending resection automatically after two attacks has largely been abandoned. Contemporary decisions incorporate severity, recurrence pattern, immune status, operative risk, and health-related quality of life. Laparoscopic resection is commonly used when feasible. Even successful removal of the affected segment cannot guarantee that all abdominal symptoms will disappear, particularly when pain arises partly from altered visceral sensitivity rather than active inflammation.
Recurrence, follow-up, and longer-term outcomes
Most people recover from an uncomplicated episode without developing a major complication. Recurrence is nevertheless common enough to shape long-term care. Population-based studies summarized in clinical guidance suggest that approximately one fifth of patients experience a recurrence within ten years after an initial episode, although estimates vary with case definitions and follow-up methods. Recurrence becomes more likely after additional episodes. A previous diverticular abscess is also associated with a higher subsequent recurrence risk than an initial uncomplicated attack.
Recurrent disease does not follow a simple pattern of progressively more dangerous attacks. Many severe complications occur during the first recognized presentation, and repeated uncomplicated episodes do not inevitably culminate in free perforation. This observation helped displace episode counting as the main criterion for elective surgery. Conversely, recurrent uncomplicated attacks can cause considerable disruption through pain, repeated investigations, absence from work, and uncertainty. Clinical severity and personal disease burden are therefore related but distinct dimensions of outcome.
Post-episode colonoscopy serves principally to exclude an alternative diagnosis, especially colorectal cancer, rather than to prove that diverticula remain present. A widely cited meta-analysis of 31 studies reported colorectal cancer in approximately 1.9% of patients evaluated after diverticulitis, with a substantially higher proportion after complicated than uncomplicated disease. This association does not establish that diverticulitis causes cancer: a pre-existing tumor can resemble or contribute to an apparent inflammatory episode. Follow-up policies differ among professional societies and depend on episode severity, CT findings, alarm features, and the quality and timing of any previous colonoscopy. When performed after an acute episode, colonoscopy is commonly delayed for about six to eight weeks or until symptoms have resolved.
Ongoing pain or altered bowel habits require distinction among persistent inflammation, a stricture, another intestinal disease, and post-inflammatory functional symptoms. “Smoldering diverticulitis” describes continuing symptoms accompanied by persistent inflammatory changes, whereas symptoms without demonstrable inflammation may overlap with irritable bowel syndrome. This distinction matters because additional antibiotics or resection may not address the source of symptoms in the latter group. Studies of elective surgery, including the DIRECT and LASER randomized trials, have found quality-of-life benefits in selected patients with recurrent attacks or persistent symptoms, alongside the risks inherent in colorectal surgery.
Long-term risk-reduction research has examined diet, physical activity, smoking, body weight, and medications. Prospective studies do not support the traditional claim that nuts, seeds, or popcorn lodge in diverticula and trigger attacks. Associations between healthier overall dietary patterns and lower diverticulitis risk are stronger than evidence for any single preventive food. Trials have not established mesalamine as effective for preventing recurrent diverticulitis, and evidence is insufficient to establish routine probiotics or cyclic rifaximin for that purpose. These findings illustrate the difference between plausible biological explanations, observational associations, and interventions demonstrated to improve clinical outcomes.